Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02661815
Title A Phase 1b Study of Weekly Paclitaxel And Oral Ricolinostat For The Treatment Of Recurrent Platinum Resistant Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Age Groups: adult
Covered Countries USA

No variant requirements are available.